Clin Exp Reprod Med.
2016 Sep;43(3):139-145. 10.5653/cerm.2016.43.3.139.
The meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian response
- Affiliations
-
- 1Department of Obstetrics and Gynecology, CHA Gumi Medical Center, Gumi, Korea.
- 2Department of Obstetrics and Gynecology, Fertility Center of CHA Gangnam Medical Center, CHA University, Seoul, Korea. wooslee@cha.ac.kr
- KMID: 2352846
- DOI: http://doi.org/10.5653/cerm.2016.43.3.139
Abstract
- Measurements of ovarian reserve play an important role in predicting the clinical results of assisted reproductive technology (ART). The ideal markers of ovarian reserve for clinical applications should have high specificity in order to determine genuine poor responders. Basal follicle-stimulating hormone levels, antral follicle count, and serum anti-Müllerian hormone (AMH) levels have been suggested as ovarian reserve tests that may fulfill this requirement, with serum AMH levels being the most promising parameter. Serum AMH levels have been suggested to be a predictor of clinical pregnancy in ART for older women, who are at a high risk for decreased ovarian response. We reviewed the prognostic significance of ovarian reserve tests for patients undergoing ART treatment, with a particular focus on the significance of serum AMH levels in patients at a high risk of poor ovarian response.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical application of serum anti-Müllerian hormone in women
- Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment
- Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
- Two Cases of Primary Ovarian Insufficiency Accompanied by High Serum Anti-Müllerian Hormone Levels and Preservation of Ovarian Follicles
- Clinical application of anti-Mullerian hormone as a predictor of controlled ovarian hyperstimulation outcome
